Top

Annals of Behavioral Medicine

Published in:

01-12-2013 | Original Article

Classifying the Reasons Men Consider to be Important in Prostate-Specific Antigen (PSA) Testing Decisions: Evaluating Risks, Lay Beliefs, and Informed Decisions

Authors: Michelle E. McDowell, Ph.D, Stefano Occhipinti, Ph.D, Suzanne K. Chambers, Ph.D

Published in: Annals of Behavioral Medicine | Issue 3/2013

Abstract

Background

Despite uncertainty regarding the benefits of prostate cancer screening, many men have had a prostate-specific antigen (PSA) test.

Purpose

This study aims to identify classes of reasons guiding men’s decisions about prostate cancer screening and predict reasoning approaches by family history and prior screening behaviour.

Methods

First-degree relatives of men with prostate cancer (n = 207) and men from the general population (n = 239) of Australia listed reasons they considered when deciding whether to have a PSA test.

Results

Responses were coded into 31 distinct categories. Latent class analysis identified three classes. The evaluation of risk information cues class (20.9 %) contained a greater number of men with a family history (compared with control and overcome cancer/risk class; 52.7 %). Informed decisions and health system class (26.5 %) included a lower proportion of men who had had a PSA test and greater proportions of highly educated and married men.

Conclusion

Understanding the reasons underlying men’s screening decisions may lead to a more effective information provision and decision support.

See McDowell et al. (11) for detailed table of participant characteristics by sample group.

Analyses were run following multiple imputation (see [27]), hence degrees of freedom for error are not always available for F statistics (in such cases, a decimal point is included in the reporting of degrees of freedom).

Twelve participants did not know if they had ever had a PSA test

Ferlay J, Shin HR, Bray F, et al. GLOBOCAN 2008, cancer incidence and mortality worldwide: IARC Cancer Base No. 10. Lyon, France: International Agency for Research on Cancer; 2010.

Baade PD, Youlden DR, Krnjacki LJ. International epidemiology of prostate cancer: Geographical distribution and secular trends. Mol Nutr Food Res. 2009;53:171–184. doi:10.1002/mnfr.200700511.PubMedCrossRef

Andriole GL, Grubb RL III, Buys SS, et al. Mortality results from a randomized prostate-cancer screening trial. New Engl J Med. 2009;360:1310–1319. doi:10.1056/NEJMoa0810696.PubMedCrossRef

Schroder FH, Hugosson J, Roobol MJ, et al. Screening and prostate-cancer mortality in a randomized European study. New Engl J Med. 2009;360:1320–1328. doi:10.1056/NEJMoa0810084.PubMedCrossRef

Moyer VA. Screening for prostate cancer: U.S. preventive services task force recommendation statement. Ann Intern Med. 2012;157:120–134.PubMedCrossRef

Brawley OW. Prostate cancer screening: What we know, don't know, and believe. Ann Intern Med. 2012;157:135–136. doi:10.7326/0003-4819-157-2-201207170-00460.PubMedCrossRef

Catalona WJ, D'Amico AV, Fitzgibbons WF, et al. What the U.S. preventive services task force missed in its prostate cancer screening recommendation. Ann Intern Med. 2012;157:137–138.PubMedCrossRef

Hoffman RM, Lewis CL, Pignone MP, et al. Decision-making processes for breast, colorectal, and prostate cancer screening: The DECISIONS survey. Med Dec Making. 2010;30:53S–64S. doi:10.1177/0272989x10378701.CrossRef

Consedine NS, Horton D, Ungar T, et al. Fear, knowledge, and efficacy beliefs differentially predict the frequency of digital rectal examination versus prostate specific antigen screening in ethnically diverse samples of older men. Am J Mens Health. 2007;1:29–43. doi:10.1177/1557988306293495.PubMedCrossRef

10.

Hevey D, Pertl M, Thomas K, et al. The relationship between prostate cancer knowledge and beliefs and intentions to attend PSA screening among at-risk men. Patient Educ Couns. 2009;74:244–249. doi:1016/j.pec.2008.08.013.PubMedCrossRef

11.

McDowell ME, Occhipinti S, Gardiner RA, Chambers SK. Patterns of PSA testing in Australian men: The influence of family history. Br J Urol Int. 2012;109:S64–S70. doi:10.1111/j.1464-410X.2012.11050.x.CrossRef

12.

Cormier L, Kwan L, Reid K, Litwin MS. Knowledge and beliefs among brothers and sons of men with prostate cancer. Urology. 2002;59:895–900. doi:10.1016/S0090-4295(01)01657-0.PubMedCrossRef

13.

Lim LS, Sherin K. ACPM Prevention Practice Committee. Screening for prostate cancer in U.S. men ACPM position statement on preventive practice. Am J Prev Med. 2008;34:164–170.PubMedCrossRef

14.

Royal Australian College of General Practitioners. Prostate screening: Policy endorsed by the 48th RACGP council, 19 April 2006. http://www.racgp.org.au/Content/NavigationMenu/Advocacy/RACGPpositionstatements/20060911Prostatescreening.pdf. Accessed November 30, 2006

15.

Royal Australian College of General Practitioners. Prostate cancer screening: Policy endorsed by the 51st RACGP Council 6 May 2009. http://www.racgp.org.au/policy/Prostate_screening.pdf. Accessed September, 2011

16.

U. S. Preventive Services Task Force. Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2008;149:185–191. http://www.annals.org/cgi/content/abstract/149/3/185

17.

U.S. Preventive Services Task Force. Screening for prostate cancer: Recommendations and rationale. Retrieved 30 December, 2007 from http://www.ahrq.gov/clinic/3rduspstf/prostatescr/prostaterr.htm

18.

Sirovich BE, Schwartz LM, Woloshin S. Screening men for prostate and colorectal cancer in the United States. JAMA: J Am Med Assoc. 2003;289:1414–1420. doi:10.1001/jama.289.11.1414.CrossRef

19.

Ross LE, Taylor YJ, Richardson LC, Howard DL. Patterns in prostate-specific antigen test use and digital rectal examinations in the behavioral risk factor surveillance system, 2002–2006. J Natl Med Assoc. 2009;101:316–324. http://www.ncbi.nlm.nih.gov/pubmed/19397221

20.

Allen JD, Othus MKD, Hart A, et al. Do men make informed decisions about prostate cancer screening? Baseline results from the "Take the Wheel" trial. Med Dec Making. 2011;31:108–120. doi:10.1177/0272989x10369002.CrossRef

21.

Hoffman RM, Couper MP, Zikmund-Fisher BJ, et al. Prostate cancer screening decisions: Results from the national survey of medical decisions (DECISIONS study). Arch Intern Med. 2009;169:1611–1618. doi:10.1001/archinternmed.2009.262.PubMedCrossRef

22.

Nijs HGT, Essink-Bot ML, DeKoning HJ, Kirkels WJ, Schroder FH. Why do men refuse or attend population-based screening for prostate cancer? J Public Health Med. 2000;22:312–316. doi:10.1093/pubmed/22.3.312.PubMedCrossRef

23.

Berglund G, Nilsson S, Nordin K. Intention to test for prostate cancer. Eur J Cancer. 2005;41:990–997. doi:10.1016/j.ejca.2005.01.011.PubMedCrossRef

24.

Steele CB, Miller DS, Maylahn C, Uhler RJ, Baker CT. Knowledge, attitudes and screening practices among older men regarding prostate cancer. Am J Public Health. 2000;90:1595–1600. doi:10.2105/AJPH.90.10.1595.PubMedCrossRef

25.

Livingston P, Cohen P, Frydenberg M, et al. Knowledge, attitudes and experience associated with testing for prostate cancer: A comparison between male doctors and men in the community. Intern Med J. 2002;32:215–223. doi:10.1046/j.1445-5994.2002.00211.x.PubMedCrossRef

26.

McDowell ME, Occhipinti S, Gardiner RA, Baade PD, Chambers SK. A review of prostate-specific antigen screening prevalence and risk perceptions for first-degree relatives of men with prostate cancer. Eur J Cancer Care (Engl). 2009;18:545–555. doi:10.1111/j.1365-2354.2008.01046.x.CrossRef

27.

McDowell ME, Occhipinti S, Chambers SK. The influence of family history on cognitive heuristics, risk perceptions, and prostate cancer screening behavior. Health Psychol. In press. doi:10.1037/a0031622.

28.

Briss P, Rimer B, Reilley B, et al. Promoting informed decisions about cancer screening in communities and healthcare systems. Am J Prev Med. 2004;26:67–80. doi:10.1016/j.amepre.2003.09.012.PubMedCrossRef

29.

Farrell MH, Murphy MA, Schneider CE. How underlying patient beliefs can affect physician–patient communication about prostate-specific antigen testing. Eff Clin Pract. 2002;5:120–129. http://europepmc.org/abstract/MED/12088291

30.

Richetin J, Conner M, Perugini M. Not doing is not the opposite of doing: Implications for attitudinal models of behavioral prediction. Pers Soc Psychol Bull. 2011;37:40–54. doi:10.1177/0146167210390522.PubMedCrossRef

31.

Weber EU, Johnson EJ. Mindful judgment and decision making. Annu Rev Psychol. 2009;60:53-85. doi:10.1146/annurev.psych.60.110707.163633.PubMedCrossRef

32.

Parrott RL, Silk KJ, Condit C. Diversity in lay perceptions of the sources of human traits: genes, environments, and personal behaviors. Soc Sci & Med. 2003;56:1099–1109. doi:10.1016/S0277-9536(02)00106-5.CrossRef

33.

Bettman JR, Park CW. Effects of prior knowledge and experience and phase of the choice process on consumer decision processes: A protocol analysis. The J Consum Res. 1980;7:234–248. http://www.jstor.org/stable/2489009

34.

Gattellari M, Ward JE. A community study using specified and unspecified scenarios to investigate men's views about PSA screening. Health Expect. 2004;7:274–289. doi:10.1111/j.1369-7625.2004.00285.x.PubMedCrossRef

35.

Vedel I, Puts MTE, Monette M, Monette J, Bergman H. The decision-making process in prostate cancer screening in primary care with a prostate-specific antigen: A systematic review. J Geriatr Oncol. 2011;2:161–176. doi:10.1016/j.jgo.2011.04.001.CrossRef

36.

Jiang L, Beals J, Zhang L, et al. Latent class analysis of stages of change for multiple health behaviors: Results from the special diabetes program for Indians diabetes prevention program. Prev Sci. 2012;13(5):449–461. doi:10.1007/s11121-011-0272-z

37.

Richert J, Schuz N, Schuz B. Stages of health behavior change and mindsets: A latent class approach. Health Psychol. 2013;32:273–282. doi:10.1037/a0028915.PubMedCrossRef

38.

McCutcheon AL. Latent Class Analysis. Newbury Park, CA: Sage Publications; 1987.

39.

Wroe AL, Salkovskis PM, Rimes KA. The prospect of predictive testing for personal risk: Attitudes and decision making. Behav Res Ther. 1998;36:599–619. doi:10.1016/S0005-7967(98)00029-1.PubMedCrossRef

40.

Chambers SK, Ferguson M, Gardiner RA, et al. ProsCan for Men: Randomised controlled trial of a decision support intervention for men with localised prostate cancer. BMC Cancer. 2008;8:207. doi:10.1186/1471-2407-8-207.PubMedCrossRef

41.

Chambers SK, Ferguson M, Gardiner RA, Aitken J, Occhipinti S. Intervening to improve psychological outcomes for men with prostate cancer. Psycho-Oncol. doi:10.1002/pon.3095

42.

Shiloh S, Gerad L, Goldman B. Patients' information needs and decision-making processes: What can be learned from genetic counselees? Health Psychol. 2006;25:211–219. doi:10.1037/0278-6133.25.2.211.PubMedCrossRef

43.

Wolf AMD, Wender RC, Etzioni RB, et al. American Cancer Society guideline for the early detection of prostate cancer: Update 2010. CA Cancer J Clin. 2010;60(2):70–98. doi:10.3322/caac.20066

44.

Muthén LK, Muthén BO. Mplus User’s Guide. Sixth Edition. Los Angeles, CA: Muthén & Muthén, 1998–2010.

45.

Muthén B, Muthén LK. Integrating person-centered and variable-centered analyses: Growth mixture modeling with latent trajectory classes. Alcohol Clin Exp Res. 2000;24:882–891. doi:10.1111/j.1530-0277.2000.tb02070.x.PubMedCrossRef

46.

Australian Bureau of Statistics. Census data 2006. http://www.abs.gov.au/websitedbs/censushome.nsf/home/Census. Accessed June 28, 2012

47.

Van Der Heijden P, Hart H, Dessens J. A parametric bootstrap procedure to perform statistical tests in a LCA of anti-social behaviour. In: Rost J, Langeheine R, eds. Applications of latent trait and latent class models in the social sciences. Münster, Germany: Waxmann; 1997:196–208.

48.

Cantor SB, Volk RJ, Cass AR, Gilani J, Spann SJ. Psychological benefits of prostate cancer screening: The role of reassurance. Health Expect. 2002;5:104–113. doi:10.1046/j.1369-6513.2002.00166.x.PubMedCrossRef

49.

Huber O, Beutter C, Montoya J, Huber OW. Risk-defusing behaviour: Towards an understanding of risky decision making. Eur J Cogn Psychol. 2001;13:409–426. doi:10.1080/09541440125915.

50.

Leventhal H, Meyer D, Nerenz D. The common sense representation of illness danger. New York, NY: Pergamon; 1980.

51.

Tversky A, Kahneman D. Availability: A heuristic for judging frequency and probability. Cogn Psychol. 1973;5:207–232.CrossRef

52.

Arora NK, McHorney CA. Patient preferences for medical decision making: Who really wants to participate? Med Care. 2000;38:335–341. doi:10.1097/00005650-200003000-00010.PubMedCrossRef

53.

Iwashyna TJ, Christakis NA. Marriage, widowhood, and health-care use. Soc Sci Med. 2003;57:2137–2147. doi:10.1016/S0277-9536(02)00546-4.PubMedCrossRef

54.

Lindström M, Rosvall M. Marital status, social capital and health locus of control: A population-based study. Publ Health. 2012;126:790–795. doi:10.1016/j.puhe.2012.06.001.CrossRef

55.

Nisbett RE, Wilson TD. Telling more than we can know: Verbal reports on mental processes. Psychol Rev. 1977;84:231–259.CrossRef

56.

Ericsson KA, Simon HA. Protocol analysis: Verbal reports as data. London, UK: MIT Press; 1993.

57.

Steginga SK, Occhipinti S. The application of the Heuristic-Systematic Processing Model to treatment decision making about prostate cancer. Med Dec Making. 2004;24:573–583. doi:10.1177/0272989X04271044.CrossRef

58.

Bowen D, Allen J, Vu T, et al. Theoretical foundations for interventions designed to promote informed decision making for cancer screening. Ann Behav Med. 2006;32:202–210. doi:10.1207/s15324796abm3203_5.PubMedCrossRef

Title: Classifying the Reasons Men Consider to be Important in Prostate-Specific Antigen (PSA) Testing Decisions: Evaluating Risks, Lay Beliefs, and Informed Decisions
Authors: Michelle E. McDowell, Ph.D
Stefano Occhipinti, Ph.D
Suzanne K. Chambers, Ph.D
Publication date: 01-12-2013
Publisher: Springer US
Published in: Annals of Behavioral Medicine / Issue 3/2013
Print ISSN: 0883-6612
Electronic ISSN: 1532-4796
DOI: https://doi.org/10.1007/s12160-013-9508-4

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Classifying the Reasons Men Consider to be Important in Prostate-Specific Antigen (PSA) Testing Decisions: Evaluating Risks, Lay Beliefs, and Informed Decisions

Abstract

Background

Purpose

Methods

Results

Conclusion

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Purpose

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 3/2013

Factors Associated with Discontinuation of Bupropion and Counseling Among African American Light Smokers in a Randomized Clinical Trial

Randomized Controlled Trial of a Behavior Change Intervention to Increase Physical Activity and Quality of Life in Prostate Cancer Survivors

Using Mental Imagery to Deliver Self-Regulation Techniques to Improve Sleep Behaviors

Depression and Anxiety Following Myocardial Infarction and Their Inverse Associations with Future Health Behaviors and Quality of Life

Association of Acute Coronary Syndrome-Induced Posttraumatic Stress Disorder Symptoms with Self-Reported Sleep

Improving Adherence to Medication in Stroke Survivors: A Pilot Randomised Controlled Trial